RegeneRx Biopharmaceuticals

(OTC) RGRX

Current Price$0.00

Market Cap$700

Since IPO (1987)-100%

5 Year-100%

1 Year+150%

1 Month+67%

RegeneRx Biopharmaceuticals Financials at a Glance

Market Cap

$700

Revenue (TTM)

$76.76K

Net Income (TTM)

$1.69M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

479.33 (High)

Dividend

$0.00

Beta (Volatility)

479.33 (High)

Price

$0.00

Volume

100

Open

$0.00

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.16

Dividend

$0.00

Beta (Volatility)

479.33 (High)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.16

RGRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RegeneRx Biopharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

J. J. Finkelstein

Website

www.regenerx.com

Headquarters

Rockville, MD 20850, US

RGRX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-18%

Net Income Margin

-22%

Return on Equity

Return on Capital

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$700.00

Shares Outstanding

1.50M

Volume

100

Avg. Volume

229.365

Financials (TTM)

Gross Profit

$76.76K

Operating Income

$1.40M

EBITDA

$1.40M

Operating Cash Flow

$940.72K

Capital Expenditure

$0.00

Free Cash Flow

$940.72K

Cash & ST Invst.

$290.89K

Total Debt

$1.45M

RegeneRx Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

$19.19K

-0.0%

Gross Profit

$19.19K

-0.0%

Gross Margin

100.00%

N/A

Market Cap

$700.00

N/A

Market Cap/Employee

$350.00

N/A

Employees

N/A

Net Income

$385.00K

+9.2%

EBITDA

$304.99K

-191718.9%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Net Cash

$1.39M

-386.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$279.69K

-76.6%

Short Term Debt

$1.21M

+3630.2%

Return on Assets

-4.52%

N/A

Return on Invested Capital

8.18%

N/A

Free Cash Flow

$189.33K

+38.2%

Operating Cash Flow

$189.33K

+38.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HMGNHemagen Diagnostics, Inc.

HMGNHemagen Diagnostics, Inc.$0.00+0.00%

FFNTF4Front Ventures Corp.

FFNTF4Front Ventures Corp.$0.00+0.00%

DRWNQuantum Medical Transport, Inc.

DRWNQuantum Medical Transport, Inc.$0.00+0.00%

NBIONascent Biotech, Inc.

NBIONascent Biotech, Inc.$0.00+0.00%

BSYIBioSyntech, Inc.

BSYIBioSyntech, Inc.$0.00+0.00%

FORZForza Innovations Inc.

FORZForza Innovations Inc.$0.00+0.00%

RASPActavia Life Sciences, Inc.

RASPActavia Life Sciences, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

Questions About RGRX

What is the current price of RegeneRx Biopharmaceuticals?

RegeneRx Biopharmaceuticals is trading at $0.00 per share.

What is the 52-week range for RegeneRx Biopharmaceuticals?

Over the past 52 weeks, RegeneRx Biopharmaceuticals has traded between $0.00 and $0.16.

How much debt does RegeneRx Biopharmaceuticals have?

As of the most recent reporting period, RegeneRx Biopharmaceuticals reported total debt of $1.45M.

How much cash does RegeneRx Biopharmaceuticals have on hand?

RegeneRx Biopharmaceuticals reported $290,890 in cash and cash equivalents in its most recent financial results.

What is RegeneRx Biopharmaceuticals’s dividend yield?

RegeneRx Biopharmaceuticals does not currently have a dividend yield.

RegeneRx Biopharmaceuticals

RegeneRx Biopharmaceuticals Financials at a Glance

RGRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About RegeneRx Biopharmaceuticals

RGRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

RegeneRx Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RGRX

What is the current price of RegeneRx Biopharmaceuticals?

What is the 52-week range for RegeneRx Biopharmaceuticals?

How much debt does RegeneRx Biopharmaceuticals have?

How much cash does RegeneRx Biopharmaceuticals have on hand?

What is RegeneRx Biopharmaceuticals’s dividend yield?

Premium Investing Services